Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fairmount Funds Management LLC Insider Profile
4 Followers
Fairmount Funds Management LLC, Director at Cogent Biosciences, holds 3.45M shares in Viridian Therapeutics (Ticker: VRDN), holds 1.60M shares in Zenas BioPharma, Inc. (Ticker: ZBIO), holds 3.21M shares in Oruka Therapeutics (Ticker: ORKA). Most recently, Fairmount Funds Management LLC Bought ― shares of Viridian Therapeutics on Sep 17, 2024 for an estimated value of 30.00M.
Fairmount Funds Management LLC Cogent Biosciences (COGT)Director
Cogent Biosciences (COGT)
Director
Ranked #1,076 out of 98,834 Corporate Insiders
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+66.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Fairmount Funds Management LLC's holdings
Insider Roles
Roles that Fairmount Funds Management LLC holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 17, 2023 - Jul 17, 2024
Return:+136.50%
The most profitable trade made by Fairmount Funds Management LLC
Fairmount Funds Management LLC's Trading History
Cogent Biosciences
Jun 12, 2024
Director
Uninformative Buy
12.90M
$65.68M
Viridian Therapeutics
Sep 17, 2024
Director, Ten Percent Owner
Informative Buy
30.00M
$72.57M
Apogee Therapeutics, Inc.
Apr 01, 2024
Director
Uninformative Buy
―
$114.73M
Dianthus Therapeutics
Apr 01, 2024
Director
Uninformative Buy
―
$71.83M
Spyre Therapeutics
Apr 25, 2024
Director
Uninformative Buy
118.18M
$139.88M
Oruka Therapeutics
Sep 13, 2024
Director, Ten Percent Owner
Uninformative Buy
6.33M
$81.52M
Zenas BioPharma, Inc.
Sep 16, 2024
Director
Uninformative Buy
―
$28.73M
List of latest transactions for each holding click on a transaction to see Fairmount Funds Management LLC's performance on stock
You May Also Like
Fairmount Funds Management LLC insider profile FAQ
What is the percentage of profitable transactions made by Fairmount Funds Management LLC?
The percentage of profitable transactions made by Fairmount Funds Management LLC is 80%.
What is the average return per transaction made by Fairmount Funds Management LLC?
The average return per transaction made by Fairmount Funds Management LLC is 66.30%.
What stocks does Fairmount Funds Management LLC hold?
Fairmount Funds Management LLC holds: COGT, VRDN, APGE, DNTH, SYRE, ORKA, ZBIO stocks.
What was Fairmount Funds Management LLC’s latest transaction?
Fairmount Funds Management LLC latest transaction was an Informative Buy of $30.00M.
What was Fairmount Funds Management LLC's most profitable transaction?
Fairmount Funds Management LLC’s most profitable transaction was an Informative Buy of APGE stock on July 17, 2023. The return on the trade was 136.50%.
What is Fairmount Funds Management LLC's role in Cogent Biosciences?
Fairmount Funds Management LLC's role in Cogent Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.